Instrument Inactif

Autres langues Harpoon Therapeutics, Inc.

Actions

Harpoon Therapeutics : April 3, 2024	03/04
Global markets live: Domino's Pizza, Generali, Oracle, Intel, Boeing...	12/03
EN DIRECTO DESDE LOS MERCADOS: Bbva, Cellnex, Repsol, Iberdrola, Solaria Energia, Neinor Homes, Ferrovial, Generali, Oracle...	12/03
Wall Street : début de semaine en repli avant le CPI	11/03
Merck Completes Acquisition of Harpoon Therapeutics	11/03
Merck : acquisition de Harpoon Therapeutics finalisée	11/03
Harpoon Therapeutics, Inc.(NasdaqCM:HARP) dropped from NASDAQ Composite Index	11/03
Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..	11/03
Harpoon Therapeutics, Inc.(NasdaqCM:HARP) dropped from S&P TMI Index	11/03
Harpoon Therapeutics : March 6, 2024	06/03
North American Morning Briefing : Stock Futures -2-	27/02
Merck overtreft verwachtingen	01/02
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	23/01
Arix Bioscience eyes USD19 million return from Harpoon sale	19/01
Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics	19/01
North American Morning Briefing : Central Bankers -2-	17/01
Merck To Buy Harpoon Therapeutics For $680 Million	17/01
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL	16/01
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP	10/01
North American Morning Briefing : Samsung Warning -2-	09/01

Aucun résultat pour cette recherche